Evotec AG today announced that Evotec and Bayer have entered into a five-year, multi-target research partnership in kidney disease. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-bayer-partner-to-develop-new-treatments-to-fight-kidney-diseases-5387